key: cord-0946075-01iud777 authors: Dalla, Keti; Bech‐Hanssen, Odd; Ricksten, Sven‐Erik title: Impact of norepinephrine on right ventricular afterload and function in septic shock—a strain echocardiography study date: 2019-08-19 journal: Acta Anaesthesiol Scand DOI: 10.1111/aas.13454 sha: f178f6b6654dc4e28b81b4ab7ab8dcb383671f2f doc_id: 946075 cord_uid: 01iud777 BACKGROUND: In this observational study, the effects of norepinephrine‐induced changes in mean arterial pressure (MAP) on right ventricular (RV) systolic function, afterload and pulmonary haemodynamics were studied in septic shock patients. We hypothesised that RV systolic function improves at higher doses of norepinephrine/MAP levels. METHODS: Eleven patients with septic shock requiring norepinephrine after fluid resuscitation were included <24 hours after ICU arrival. Study enrolment and insertion of a pulmonary artery catheter was performed after written informed consent from the next of kin. Norepinephrine infusion was titrated to target mean arterial pressures (MAP) of 60, 75 and 90 mmHg in a random sequential order. At each target MAP, strain—and conventional echocardiographic—and pulmonary haemodynamic variables were measured. RV afterload was assessed as effective pulmonary arterial elastance, (E (pa)) and pulmonary vascular resistance index, (PVRI). RV free wall peak strain was the primary end‐point. RESULTS: At highest compared to lowest norepinephrine dose/MAP level, RV free wall peak strain increased from −19% to −25% (32%, P = .003), accompanied by increased tricuspid annular plane systolic excursion (22%, P = .01). At the highest norepinephrine dose/MAP, RV end‐diastolic area index (16%, P < .001), central venous pressure (38%, P < .001), stroke volume index (7%, P = .001), mean pulmonary artery pressure (19%, P < .001) and RV stroke work index (15%, P = .045) increased, with no effects on PVRI or E (pa). Cardiac index did not change, assessed by thermodilution (P = .079) and echocardiography (P = .054). CONCLUSIONS: Higher doses of norepinephrine to a target MAP of 90 mm Hg improved RV systolic function while RV afterload was not affected. in sepsis due to increased pulmonary vascular resistance (PVR) 8 particularly in septic patients with associated acute lung injury requiring mechanical ventilation. 9 Norepinephrine has the potential to further increase RV afterload by an alpha-mediated pulmonary vasoconstriction in septic patients. 10, 11 On the other hand, norepinephrine may increase RV systolic function by its β 1 -receptor agonistic effect. 12 In addition, norepinephrine has been shown to increase both RV and LV preload, by alpha-mediated constriction of systemic venous capacitance vessels causing an increase in intrathoracic blood volume. 13 Strain echocardiography is a relatively new and promising method for assessment of myocardial systolic function, as it can differentiate between active and passive (scar) movement of myocardial segments. Speckle-tracking echocardiography measures the relative movement of myocardial greyscale alterations (speckle patterns) and can thereby quantify systolic deformation, strain, describing percentage changes in myocardial segment length. The most frequently used strain variable is global longitudinal strain (GLS), which has been introduced for the detection of LV dysfunction. 14 In sepsis, strain imaging has the ability to detect impaired LV 15, 16 systolic function not appreciated by conventional echocardiography. RV systolic function can also be evaluated with strain echocardiography by assessment of RV free wall strain. In sepsis/septic, shock it has been shown that RV free wall peak strain is considerably reduced 15, 16 and that severely reduced RV free wall strain was associated with increased 6-month mortality. 15 Our aim was to investigate the immediate effects of changes in norepinephrine infusion rates/MAP levels on RV systolic function and RV afterload, in patients with septic shock, by the combined use of strain echocardiography and a pulmonary artery thermodilution catheter for assessment of pulmonary haemodynamics. We tested the hypothesis that higher norepinephrine infusion rates/ MAP levels improve RV systolic function in patients with norepinephrine-dependent septic shock despite the potential increase in RV afterload. The study was approved by the Regional Ethical Review Board in Gothenburg (www.epn.se) (protocol 325-15, approved 20 June 2015). The study was registered at ClinicalTrials.gov (NCT02640846, in 29 December 2015). Data from the first part of this protocol are presented. Written informed consent was obtained from the patient's next of kin. We included 11 patients admitted with septic shock to the gen- Systolic (SAP), mean (MAP) and diastolic arterial blood pressure were measured invasively by a radial artery catheter. Each patient underwent a catheterisation with a 7.5-F pulmonary artery catheter (PAC) (Baxter Healthcare, Irvine CA) for the purpose of the study protocol. Cardiac output (CO) and stroke volume were measured by thermodilution technique (PAC) (mean of three 10-mL ice-cold saline injections) and indexed to the body surface area to receive cardiac index (CI) and stroke volume index (SVI). The coefficient of variation for CO measurements was < 10% in all patients. Heart rate (HR), arterial blood pressure, systolic and mean pulmo- E pa incorporates all elements of total RV afterload, including vascular resistance, arterial compliance and characteristic impedance. Strain measurements were performed offline in the four-chamber, long-axis and two-chamber views. All offline analyses were per- After the insertion of the pulmonary artery catheter the norepinephrine dose was adjusted to obtain a target mean arterial pressure (MAP) of 75 mmHg (baseline). Measurement of systemic and pulmonary haemodynamics, as well as, an echocardiographic examination was performed twice at this target MAP. All patients were then subjected to target MAP:s of 60 and 90 mmHg, in a random order, for a period of at least 10 minutes, excluding wash-in/wash-out periods, by decreasing/increasing the infusion rate of norepinephrine ( Figure 1 ). The wash-in/wash-out periods lasted for approximately 5-10 minutes. One of the investigators performed the haemodynamic measurements and dose adjustments and another the echocardiographic examination, both blinded to each other's findings. At the end of each period, haemodynamic and echocardiographic measurements were performed. Fluid infusion rates and ventilatory settings were not changed during the experimental procedure. From the two baseline measurements, the intra-observer agreement for each of the variables, RV free wall peak strain and LV global longitudinal strain, was assessed by the coefficients of variation for paired observations. Inter-observer variation was not assessed. The mean of the first and second measurements at baseline were calculated (baseline). The primary outcome variable was RV free wall peak strain. To detect a norepinephrine-induced 30% relative change in RV free wall peak strain at the highest compared to lowest nor- Eleven patients were included in the study, 7 male and 4 females, with a mean age of 63 ± 10 ( Table 1 ). All patients were studied within 24 hours after the ICU arrival (12 ± 6 hours). The mean SAPS 3 score and SOFA score on ICU arrival were 62 ± 12 and 10 ± 3, respectively. Patient characteristics, clinical data, sources of infection and mortality are presented in Tables 1 and 2 . None of the patients received any vasopressor or inotropic drug other than norepinephrine. Our data were normally distributed, as tested by the Kolmogorov-Smirnov test. The doses of norepinephrine to obtain target MAP:s of 60, 75 and 90 mmHg were 0.16 (0.10-0.40), 0.36 (0.18-0.59) and 0.49 (0.23-0.69) µg/kg/min, respectively. Highest compared to lowest norepinephrine dose/MAP level was accompanied by increases in SVI (7%, P = .001, ANOVA), MPAP (19%, P < .001), PCWP (50%, P < .001) CVP (38%, P < .001), SVRI (47%, P < 0.001), LVSWI (39%, P < .001) and RVSWI (15%, P = .045), and a decrease in PVRI/SVRI ratio (35%, P < .001). PVRI or heart rate was not affected by the norepinephrine infusion rate/MAP level. Neither CO (P = .075) nor CI (P = .079) changed significantly comparing the highest to the lowest norepinephrine dose/MAP level. E a increased by 36% (P < .001), while E pa was not significantly affected by the norepinephrine/MAP level (−15%, P = .133). All patients were in sinus rhythm during the performance of the experimental protocol (Table 3 , Figure 3A -D). At baseline (75 mmHg), the ventilator-induced variation in SV, assessed by echocardiography was 9.2 ± 4.5%. Data on RV free wall peak strain and RVEDAI are missing from one patient. Impaired RV function, was seen in 7/11 (64%) patients at baseline (75 mmHg). Highest compared to lowest norepinephrine dose/MAP level was accompanied by improved RV systolic function as reflected by a change in RV free wall peak strain from −19 ± 4 to −25 ± 5 (P = .003, ANOVA), a 22% increase in TAPSE (P = .010) and a 18% increase of tricuspid annular systolic velocity S′ (P = .029). RVEDAI increased significantly by 16% (P < .001) and SVI increased by 17% (P = .012). Neither CO (P = .066), CI (P = .054) nor LVEDV (P = .070) changed significantly at higher doses of norepinephrine/MAP levels. LV ejection fraction or LV GLS were not affected with higher doses of norepinephrine/MAP levels (Table 4, Figure 2 , Figure 3A -D). The intra-observer coefficient of variation for paired measurements of RV free wall peak strain and LV global longitudinal strain were 10% and 6%, respectively. The main findings were that RV function improved with increasing doses of norepinephrine, as assessed both by strain and conventional echocardiography. Furthermore, neither PVRI nor effective pulmonary arterial elastance (E pa ), a measure of the total RV afterload, was It has previously been shown that the RV free wall strain in patients without cardiopulmonary disease ranges between −24% and −29 with a mean of −27 ± 2%. 19 In the present study, 64% of the patients had a RV free wall strain > −24%, with a mean of −21 ± 5% at baseline (75 mmHg), suggesting that RV function was compromised, confirming previous strain echocardiographic studies on patients with severe sepsis. 15 Ventricular strain is a load-dependent myocardial deformation variable, which is sensitive to changes in preload, as shown in a clinical strain echocardiographic study. 21 Furthermore, an increase in inotropic stimulation increases ventricular strain, also when preload and afterload are controlled. 22 In the present study, the NE-associated improvement in RV free wall strain was, most likely, caused by an increase in RV preload. A more or less, positive β 1 -receptor-mediated inotropic effect could also contribute to the improved RV performance with norepinephrine. LV contraction may also contribute to RV ejection mediated through septal contraction. 23 Although we did not measure the degree of septal contraction in the present study, we believe it is unlikely that the improvement in RV systolic function, induced by norepinephrine, was caused by enhanced septal contraction, as norepinephrine did not induced changes in LV systolic function. They attributed this beneficial effect of norepinephrine to a restoration of a low diastolic arterial pressure, which would improve coronary perfusion and LV performance and/or a norepinephrine-induced stimulation of upregulated β 1 -adrenergic receptors. The major limitation of the present study are the small number of patients, the prolonged inclusion window and the low inclusion ratio from screened patients with a risk for indication, selection and spectrum bias. Another limitation is that the lowest MAP (60 mmHg), used in the present study, is not supported by guidelines for management of septic shock (≥65 mmHg). Another limitation is that we only studied the acute effects of NE on cardiac function and pulmonary haemodynamics and we can therefore not draw conclusions on the potential long-term effects of norepinephrine on these variables in septic shock. The strength of this study is that data on RV and LV deformation, as well as, pulmonary and systemic haemodynamics, including pulmonary vascular resistance, RV and LV arterial elastance and RV and LV preload, were simultaneously obtained from the same patient. We conclude that in this cohort of septic shock patients, variation in norepinephrine infusion rates to achieve target MAP:s in the range of 60-75 and 90 mmHg, appears to lead to increased RV free wall peak systolic strain findings, indicating better right ventricular systolic function at the higher norepinephrine infusion rates/MAP levels. The mechanisms behind this improvement could be an increase in RV preload, caused by a norepinephrine-induced venoconstriction and increased myocardial contractility, together with a neutral effect of norepinephrine on pulmonary vascular resistance and RV afterload. This study was supported by grants from the Swedish State under the agreement between the Swedish government and the county councils, the ALF-agreement (ALFGBG-73450 and 75 130) and Gothenburg Medical Society. None of the authors have any conflict of interest to declare. https://orcid.org/0000-0001-7367-2500 Sven-Erik Ricksten https://orcid.org/0000-0002-1445-7525 The third international consensus definitions for sepsis and septic shock Chamber Quantification Writing G, American Society of Echocardiography's G, Standards C, European Association of E. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology Assessment of right ventricular functions in patients with sepsis, severe sepsis and septic shock and its prognostic importance: a tissue Doppler study Speckle tracking echocardiography in patients with septic shock: a case control study (SPECKSS) Prognostic impact of isolated right ventricular dysfunction in sepsis and septic shock: an 8-year historical cohort study Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock Actual incidence of global left ventricular hypokinesia in adult septic shock Pulmonary hypertension in sepsis: measurement by the pulmonary arterial diastolic-pulmonary wedge pressure gradient and the influence of passive and active factors Pulmonary hypertension in the intensive care unit Effects of norepinephrine on right ventricular function in septic shock patients Effect of dopamine vs norepinephrine on hemodynamics in septic shock. Emphasis on right ventricular performance Vasoactive drugs in circulatory shock Norepinephrine increases cardiac preload and reduces preload dependency assessed by passive leg raising in septic shock patients Noninvasive myocardial strain measurement by speckle tracking echocardiography: validation against sonomicrometry and tagged magnetic resonance imaging Outcome prediction in sepsis: speckle tracking echocardiography based assessment of myocardial function Strain echocardiography identifies impaired longitudinal systolic function in patients with septic shock and preserved ejection fraction Contribution of systemic vascular resistance and total arterial compliance to effective arterial elastance in humans Effective arterial elastance as an index of pulmonary vascular load Reference values for right ventricular strain in patients without cardiopulmonary disease: a prospective evaluation and meta-analysis The Anrep effect: 100 years later Load-dependence of myocardial deformation variables-a clinical strain-echocardiographic study Inotropic and lusitropic effects of levosimendan and milrinone assessed by strain echocardiography-a randomised trial Anatomy, function, and dysfunction of the right ventricle: JACC state-of-the-art review Norepinephrine exerts an inotropic effect during the early phase of human septic shock Adrenergic mechanisms in canine intralobar pulmonary arteries and veins Demonstration of both beta 1-and beta 2-adrenoceptors mediating relaxation of isolated ring preparations of rat pulmonary artery Pharmacological analysis of norepinephrine responses in rabbit pulmonary blood vessels Terlipressin or norepinephrine in hyperdynamic septic shock: a prospective, randomized study Increasing mean arterial pressure in patients with septic shock: effects on oxygen variables and renal function Effects of norepinephrine on renal perfusion, filtration and oxygenation in vasodilatory shock and acute kidney injury Effects of changes in arterial pressure on organ perfusion during septic shock Flow-dependent regulation of endothelial nitric oxide synthase: role of protein kinases